The impact of complete surgical staging upon survival in early-stage ovarian clear cell carcinoma: a multi-institutional retrospective study. 2009

Masashi Takano, and Toru Sugiyama, and Nobuo Yaegashi, and Mitsuaki Suzuki, and Hiroshi Tsuda, and Satoru Sagae, and Yasuhiro Udagawa, and Kazuo Kuzuya, and Junzo Kigawa, and Satoshi Takeuchi, and Hitoshi Tsuda, and Takuya Moriya, and Yoshihiro Kikuchi
Department of Obstetrics and Gynecology, National Defense Medical College, Tokorozawa, Saitama, Japan. mastkn@ndmc.ac.jp

Pure-type clear cell carcinoma (CCC) has been recognized as a distinct subtype of ovarian cancer, showing resistance to conventional platinum-based chemotherapy and resulting in poor prognosis. The aim of the study was to evaluate the effects of complete surgical staging procedures for early-stage CCC patients in a retrospective multi-institutional analysis. During the period 1992 to 2002, a total of 199 patients with pT1 M0 CCC were identified. Survival analysis was estimated by Kaplan-Meier methods, and prognostic factors were evaluated using a Cox regression model. Among pT1 M0 tumors, retroperitoneal lymph node status was negative in 125 cases (pN0, 63%), positive in 10 cases (pN1, 5%), and unknown in 64 cases (pNx, 32%). Progression-free survival of pN1 was significantly worse than that of pN0 (P < 0.05), whereas there was no significant difference between pN1 and pNx. There was no significant difference of overall survival (OS) among the 3 groups. Multivariate analysis revealed that peritoneal cytology status was the only independent prognostic factor for progression-free survival (P = 0.04), but completion of surgical staging procedures was not a prognostic factor. There was no significant prognostic factor for OS. Our study implied that complete surgical staging enabled us to distinguish a high-risk group of recurrence in pT1 M0 CCC; however, the procedure could not improve OS. Although the study was a limited retrospective study, the impact of peritoneal cytology status was more important than complete surgical staging procedure in CCC patients. More effective treatment modality was warranted, especially for CCC cases positive for malignant peritoneal cytology.

UI MeSH Term Description Entries
D008197 Lymph Node Excision Surgical excision of one or more lymph nodes. Its most common use is in cancer surgery. (From Dorland, 28th ed, p966) Lymph Node Dissection,Lymphadenectomy,Dissection, Lymph Node,Dissections, Lymph Node,Excision, Lymph Node,Excisions, Lymph Node,Lymph Node Dissections,Lymph Node Excisions,Lymphadenectomies,Node Dissection, Lymph,Node Dissections, Lymph
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002288 Adenocarcinoma, Mucinous An adenocarcinoma producing mucin in significant amounts. (From Dorland, 27th ed) Carcinoma, Colloid,Carcinoma, Mucinous,Adenocarcinomas, Mucinous,Carcinomas, Colloid,Carcinomas, Mucinous,Colloid Carcinoma,Colloid Carcinomas,Mucinous Adenocarcinoma,Mucinous Adenocarcinomas,Mucinous Carcinoma,Mucinous Carcinomas
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

Masashi Takano, and Toru Sugiyama, and Nobuo Yaegashi, and Mitsuaki Suzuki, and Hiroshi Tsuda, and Satoru Sagae, and Yasuhiro Udagawa, and Kazuo Kuzuya, and Junzo Kigawa, and Satoshi Takeuchi, and Hitoshi Tsuda, and Takuya Moriya, and Yoshihiro Kikuchi
January 2011, Gynecologic and obstetric investigation,
Masashi Takano, and Toru Sugiyama, and Nobuo Yaegashi, and Mitsuaki Suzuki, and Hiroshi Tsuda, and Satoru Sagae, and Yasuhiro Udagawa, and Kazuo Kuzuya, and Junzo Kigawa, and Satoshi Takeuchi, and Hitoshi Tsuda, and Takuya Moriya, and Yoshihiro Kikuchi
March 2021, Japanese journal of clinical oncology,
Masashi Takano, and Toru Sugiyama, and Nobuo Yaegashi, and Mitsuaki Suzuki, and Hiroshi Tsuda, and Satoru Sagae, and Yasuhiro Udagawa, and Kazuo Kuzuya, and Junzo Kigawa, and Satoshi Takeuchi, and Hitoshi Tsuda, and Takuya Moriya, and Yoshihiro Kikuchi
May 2023, BMC women's health,
Masashi Takano, and Toru Sugiyama, and Nobuo Yaegashi, and Mitsuaki Suzuki, and Hiroshi Tsuda, and Satoru Sagae, and Yasuhiro Udagawa, and Kazuo Kuzuya, and Junzo Kigawa, and Satoshi Takeuchi, and Hitoshi Tsuda, and Takuya Moriya, and Yoshihiro Kikuchi
December 2014, Gynecologic oncology,
Masashi Takano, and Toru Sugiyama, and Nobuo Yaegashi, and Mitsuaki Suzuki, and Hiroshi Tsuda, and Satoru Sagae, and Yasuhiro Udagawa, and Kazuo Kuzuya, and Junzo Kigawa, and Satoshi Takeuchi, and Hitoshi Tsuda, and Takuya Moriya, and Yoshihiro Kikuchi
February 2017, Gynecologic oncology,
Masashi Takano, and Toru Sugiyama, and Nobuo Yaegashi, and Mitsuaki Suzuki, and Hiroshi Tsuda, and Satoru Sagae, and Yasuhiro Udagawa, and Kazuo Kuzuya, and Junzo Kigawa, and Satoshi Takeuchi, and Hitoshi Tsuda, and Takuya Moriya, and Yoshihiro Kikuchi
September 2022, World journal of surgical oncology,
Masashi Takano, and Toru Sugiyama, and Nobuo Yaegashi, and Mitsuaki Suzuki, and Hiroshi Tsuda, and Satoru Sagae, and Yasuhiro Udagawa, and Kazuo Kuzuya, and Junzo Kigawa, and Satoshi Takeuchi, and Hitoshi Tsuda, and Takuya Moriya, and Yoshihiro Kikuchi
November 2016, Gynecologic oncology,
Masashi Takano, and Toru Sugiyama, and Nobuo Yaegashi, and Mitsuaki Suzuki, and Hiroshi Tsuda, and Satoru Sagae, and Yasuhiro Udagawa, and Kazuo Kuzuya, and Junzo Kigawa, and Satoshi Takeuchi, and Hitoshi Tsuda, and Takuya Moriya, and Yoshihiro Kikuchi
May 2012, Annals of surgical oncology,
Masashi Takano, and Toru Sugiyama, and Nobuo Yaegashi, and Mitsuaki Suzuki, and Hiroshi Tsuda, and Satoru Sagae, and Yasuhiro Udagawa, and Kazuo Kuzuya, and Junzo Kigawa, and Satoshi Takeuchi, and Hitoshi Tsuda, and Takuya Moriya, and Yoshihiro Kikuchi
August 2009, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society,
Masashi Takano, and Toru Sugiyama, and Nobuo Yaegashi, and Mitsuaki Suzuki, and Hiroshi Tsuda, and Satoru Sagae, and Yasuhiro Udagawa, and Kazuo Kuzuya, and Junzo Kigawa, and Satoshi Takeuchi, and Hitoshi Tsuda, and Takuya Moriya, and Yoshihiro Kikuchi
March 2003, Gynecologic oncology,
Copied contents to your clipboard!